A massive research collaboration between 13 pharmaceutical companies and the UK Biobank has uncovered a trove of new leads for drug targets and diagnostic biomarkers, revealing thousands of previously unknown associations with common genetic variants and proteins circulating in the blood.
The work, known as the Pharma Proteomics Project, has…
Click here to view original post
